Technical Notes

3 06, 2025

Ensuring Data Integrity and 21 CFR Part 11 Compliance in NGS Workflows
Gallery

Ensuring Data Integrity and 21 CFR Part 11 Compliance in NGS Workflows

Joshua Fu2025-06-27T17:47:57+00:00

Avance delivers end-to-end NGS workflow compliance with a robust framework for data integrity, pipeline validation, and audit readiness—tailored for regulated environments...

Ensuring Data Integrity and 21 CFR Part 11 Compliance in NGS WorkflowsJoshua Fu2025-06-27T17:47:57+00:00

14 03, 2024

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide
Gallery

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive Guide

Xuening Huang2025-06-24T13:54:49+00:00

This comprehensive guide explores the essential tools of quantitative PCR (qPCR) and digital droplet PCR (ddPCR) in the biopharmaceutical industry, offering invaluable insights into their applications, strengths, and limitations. Download now to stay ahead of the curve in pharmaceutical research and development...

qPCR or ddPCR for Bioanalysis? – Download our Comprehensive GuideXuening Huang2025-06-24T13:54:49+00:00

Avance Biosciences Expands Bioanalytical Testing Capabilities with New LC-MS/MS Services

Join Avance at BioProcess International – September 15-18, 2025

Avance Biosciences Launches NGS Center of Excellence in Houston

Join Avance at the BioProcessing Summit – August 18-21, 2025

Avance is growing to better support biopharmaceutical drug development and manufacturing

Ensuring Data Integrity and 21 CFR Part 11 Compliance in NGS Workflows